MARKET

CAH

CAH

Cardinal Health
NYSE

Real-time Quotes | Nasdaq Last Sale

53.49
+1.29
+2.47%
After Hours: 53.99 +0.5 +0.93% 18:52 03/05 EST
OPEN
52.50
PREV CLOSE
52.20
HIGH
53.68
LOW
51.93
VOLUME
2.49M
TURNOVER
--
52 WEEK HIGH
59.46
52 WEEK LOW
39.05
MARKET CAP
15.71B
P/E (TTM)
11.39
1D
5D
1M
3M
1Y
5Y
Cardinal Health Inc. stock outperforms competitors on strong trading day
Shares of Cardinal Health Inc. rose 2.47% to $53.49 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...
marketwatch.com · 1d ago
U.S. House panel probes four cos. over tax deductions, opioid settlements -statement
reuters.com · 2d ago
Global Stents Market Report 2021-2027 - Trend of Coronary Stent Price Slashing and Increasing Competitiveness of Domestic Players in APAC Countries
Dublin, March 05, Mar 05, 2021 (GLOBE NEWSWIRE via COMTEX) -- Dublin, March 05, 2021 (GLOBE NEWSWIRE) -- The "Global Stents Market, Forecast to 2027" report...
GlobeNewswire · 2d ago
Hydrogen Peroxide Gas Plasma Market Growth Analysis with Sales Estimation 2021: Forecast Value and Industry Size Analysis by Leading Players, Business Development Outlook with Top Regions with Impact of Covid-19 till 2025
Mar 05, 2021 (The Expresswire) -- "Final Report will add the analysis of the impact of COVID-19 on this industry." Global “Hydrogen Peroxide Gas Plasma...
The Express Wire · 2d ago
Diabetic Foot Ulcer Treatment Market Size, Share and Forecast 2019-2025
Mar 05, 2021 (Market Insight Reports) -- The global diabetic foot ulcer treatment market is anticipated to grow at a CAGR of around 7% during the forecast...
Market Insight Reports · 2d ago
Diagnostic Catheter Market Revenue Growth Predicted by 2021-2025|Says Kenneth Research
Mar 04, 2021 (AmericaNewsHour) -- The global Diagnostic Catheter Market was valued at USD 3 billion in 2016 and is projected to reach USD 5.62billion by...
AmericaNewsHour · 2d ago
Nuclear Medicine/Radio pharmaceuticals market Witness Widespread Expansion during 2021-2025|Says Kenneth Research
Mar 04, 2021 (AmericaNewsHour) -- The global Nuclear Medicine/Radio pharmaceuticals market was valued at USD 4.63billion in 2016 and is projected to reach...
AmericaNewsHour · 2d ago
Global Sterilization Biological Indicators Market Share 2020 | Covid-19 Impact Analysis, Upcoming Trends, Industry Segments, Growth, Size, Landscape and Demand by Forecast to 2025
Mar 04, 2021 (The Expresswire) -- Global “Sterilization Biological Indicators Market” research report 2021-2025 is a specialized and in-depth study of the...
The Express Wire · 2d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of CAH. Analyze the recent business situations of Cardinal Health through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 20 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average CAH stock price target is 62.94 with a high estimate of 72.00 and a low estimate of 57.00.
EPS
Institutional Holdings
Institutions: 1.15K
Institutional Holdings: 263.28M
% Owned: 89.65%
Shares Outstanding: 293.67M
TypeInstitutionsShares
Increased
260
10.58M
New
166
483.27K
Decreased
264
12.69M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Drug Retailers
+1.36%
Food & Drug Retailing
+1.41%
Key Executives
Non-Executive Chairman/Independent Director
Gregory Kenny
Chief Executive Officer/Director
Michael Kaufmann
Chief Financial Officer
Jason Hollar
Corporate Executive
Victor Crawford
Corporate Executive
Stephen Mason
Chief Human Resource Officer
Ola Snow
Executive Vice President/Chief Information Officer
Brian Rice
Director
J. Michael Losh
Director
John Michael Losh
Chief Compliance Officer
Jessica Mayer
Independent Director
Carrie Cox
Independent Director
Calvin Darden
Independent Director
Bruce Downey
Independent Director
Sheri Edison
Independent Director
David Evans
Independent Director
Patricia Hemingway Hall
Independent Director
Akhil Johri
Independent Director
Nancy Killefer
Independent Director
John Losh
Independent Director
Dean Scarborough
Independent Director
John Weiland
Declaration Date
Dividend Per Share
Ex-Div Date
02/05/2021
Dividend USD 0.4859
03/31/2021
11/05/2020
Dividend USD 0.4859
12/31/2020
08/06/2020
Dividend USD 0.4859
09/30/2020
05/11/2020
Dividend USD 0.4859
06/30/2020
02/11/2020
Dividend USD 0.4811
03/31/2020
11/07/2019
Dividend USD 0.4811
12/31/2019
08/07/2019
Dividend USD 0.4811
09/30/2019
05/08/2019
Dividend USD 0.4811
06/28/2019
02/07/2019
Dividend USD 0.4763
03/29/2019
11/07/2018
Dividend USD 0.476
12/31/2018
08/08/2018
Dividend USD 0.476
09/28/2018
05/09/2018
Dividend USD 0.476
06/29/2018
02/07/2018
Dividend USD 0.462
03/29/2018
11/08/2017
Dividend USD 0.462
12/29/2017
08/10/2017
Dividend USD 0.462
09/29/2017
05/04/2017
Dividend USD 0.462
06/29/2017
02/03/2017
Dividend USD 0.449
03/30/2017
11/04/2016
Dividend USD 0.449
12/29/2016
08/08/2016
Dividend USD 0.449
09/29/2016
05/05/2016
Dividend USD 0.449
06/29/2016
02/03/2016
Dividend USD 0.387
03/30/2016
11/05/2015
Dividend USD 0.387
12/30/2015
08/06/2015
Dividend USD 0.387
09/29/2015
05/06/2015
Dividend USD 0.387
06/29/2015
02/04/2015
Dividend USD 0.343
03/30/2015
11/05/2014
Dividend USD 0.343
12/30/2014
08/06/2014
Dividend USD 0.343
09/29/2014
05/07/2014
Dividend USD 0.343
06/27/2014
02/05/2014
Dividend USD 0.303
03/28/2014
11/06/2013
Dividend USD 0.303
12/30/2013
08/07/2013
Dividend USD 0.303
09/27/2013
About CAH
Cardinal Health, Inc. is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies. The Medical segment distributes a range of medical, surgical and laboratory products, and provides services to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers. This segment also manufactures, sources and develops its own Cardinal Health brand medical and surgical products. It provides post-acute care management and transition services, and software to hospitals.

Webull offers kinds of Cardinal Health Inc stock information, including NYSE:CAH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CAH stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CAH stock methods without spending real money on the virtual paper trading platform.